Abiraterone in the treatment of metastatic castration-resistant prostate cancer
Elahe A Mostaghel Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Abstract: Androgen deprivation therapy remains the single most effective treatment for the initial therapy of advanced prostate cancer, but is uniformly marked by progression to castration-resi...
Spremljeno u:
| Glavni autor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2014-01-01
|
| Serija: | Cancer Management and Research |
| Online pristup: | http://www.dovepress.com/abiraterone-in-the-treatment-of-metastatic-castration-resistant-prosta-a15635 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|